|Articles|April 1, 2022

LCGC Supplements

  • Recent Developments in Biopharmaceutical Analysis
  • Volume 40
  • Issue s4

Recent Developments in Biopharmaceutical Analysis European PDF

Click the image below to access the LCGC Europe Supplement 'Recent Developments in Biopharmaceutical Analysis'

Articles in this issue

over 3 years ago

State-of-the-Art Biopharmaceutical Analysis

over 3 years ago

Improving Selectivity in the Chromatographic Analysis of Monoclonal Antibodies (mAbs) Through the Use of Multi-Isocratic Elution Mode

over 3 years ago

Analytical Applications of Immobilized Enzyme Reactors (IMERs) Coupled to LC–MS/MS for Bottom- and Middle-Up Characterization of Proteins

over 3 years ago

The Power of Trypsin Immobilized Enzyme Reactors (IMERs) Deployed in Online MDLC–MS Applications

over 3 years ago

Online HPLC–HRMS Platform: The Next-Generation Process Analytical Technology Tool for Real-Time Monitoring of Antibody Quality Attributes in Biopharmaceutical Processes

over 3 years ago

Multi-Attribute Monitoring and the Multi-Attribute Method: A Powerful Double Act for Supporting Biopharmaceutical Manufacturing

over 3 years ago

New Aspects in the Integration of MS Technologies in the Biopharmaceutical Industry

over 3 years ago

Perspectives on the Use of Retention Modeling to Streamline 2D-LC Method Development: Current State and Future Prospects

Newsletter

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Subscribe Now!